Liver in haematological disorders

Best Pract Res Clin Gastroenterol. 2013 Aug;27(4):513-30. doi: 10.1016/j.bpg.2013.06.012.

Abstract

Prothrombotic haematological disorders, in particular myeloproliferative disorders, are identified in a significant proportion of patients with Budd-Chiari syndrome and portal vein thrombosis (PVT). Multiple prothrombotic disorders may coexist. PVT is diagnosed in one fourth of patients with cirrhosis and is more common with advanced liver disease and hepatocellular carcinoma. PVT in cirrhosis can precipitate decompensation. Intrahepatic microthrombosis may play a role in the pathogenesis of hepatic fibrosis. Sinusoidal obstruction syndrome is usually a complication of myeloablative treatment before haematopoietic stem cell transplantation. Post-transplant lymphoproliferative disorders can complicate liver transplantation and are related to Epstein-Barr virus infection. Hepatitis B reactivation in patients receiving chemotherapy for haematological malignancies is very common without pre-emptive treatment, and can lead to liver failure. Liver involvement is common in primary haematological diseases, such as haemolytic anaemias, lymphomas and leukaemia.

Keywords: Budd–Chiari syndrome; Myeloproliferative disorders; Portal vein thrombosis; Post-transplant lymphoproliferative disorders; Sinusoidal obstruction syndrome.

Publication types

  • Review

MeSH terms

  • Budd-Chiari Syndrome / physiopathology*
  • Humans
  • Liver / physiopathology*
  • Myeloproliferative Disorders / physiopathology*
  • Portal Vein / physiopathology*
  • Venous Thrombosis / physiopathology*